Location History:
- Basel, CH (2003 - 2006)
- Weil am Rhein, DE (2010)
Company Filing History:
Years Active: 2003-2010
Title: Berthold Schenkel: Innovator in Organic Chemistry
Introduction
Berthold Schenkel is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of organic chemistry, holding a total of 3 patents. His work focuses on the synthesis and purification of complex organic compounds, which are essential in various pharmaceutical applications.
Latest Patents
Schenkel's latest patents include a process for the synthesis of organic compounds. This invention provides an efficient, safe, and cost-effective way to prepare 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine, which serves as an intermediate for the preparation of substituted pyrimidinylaminobenzamides. Another significant patent is related to a purification process. This invention outlines a method for purifying cyclosporin, specifically cyclosporin A, to a high degree of purity on a large scale. It also provides a bulk quantity of cyclosporin A with an impurity level of less than about 0.7%, enhancing its usability in medical applications.
Career Highlights
Berthold Schenkel is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in drug development and synthesis. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Schenkel has collaborated with notable colleagues such as Peter Fuenfschilling and Murat Acemoglu. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
In summary, Berthold Schenkel is a distinguished inventor whose work in organic chemistry has led to valuable patents and advancements in pharmaceutical research. His contributions continue to impact the industry positively.